BUY, SELL, HOLD (2)

Capricor Therapeutics Inc (CAPR) Stock Soars on Drug Data

Biotech stock Capricor Therapeutics Inc (CAPR) is on pace for its best finish since August

Jun 16, 2016 at 2:52 PM
facebook X logo linkedin


Biotech stock Capricor Therapeutics Inc (NASDAQ:CAPR) is shooting higher today, picking up 14.5% at $4.75, thanks to upbeat data from the company's heart failure treatment. The shares were up as much as 30% earlier, and building off of Wednesday's 17% gain, they're now on pace for their highest close since August. However, this doesn't offer much solace to long-term shareholders. 

Specifically, CAPR has lost over half its value since hitting an annual high of $10.68 in March 2015. And things don't get any better if you expand the timeline, as the stock flirted with $50 in mid-2011. In other words, while CAPR has made a valiant rebound effort in 2016, it remains a long-term laggard.

Short sellers would like to see the shares resume this lackluster technical performance. Short sellers control more than eight days' worth of buying power on CAPR, based on its typical trading levels -- with short interest jumping over 7% in the last reporting period alone.

If these bears have any luck, Capricor Therapeutics Inc (NASDAQ:CAPR) stock could soon let off some steam, after its recent burst. At Wednesday's close, CAPR's 14-day Relative Strength Index (RSI) arrived at 68 -- just short of overbought territory. 

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.